BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bader SM, Cooney JP, Pellegrini M, Doerflinger M. Programmed cell death: the pathways to severe COVID-19? Biochem J 2022;479:609-28. [PMID: 35244141 DOI: 10.1042/BCJ20210602] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Khan SA, Lee TKW. Identifying potential pharmacological targets and molecular pathways of Meliae cortex for COVID-19 therapy. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1128164] [Reference Citation Analysis]
2 Minkoff JM, tenOever B. Innate immune evasion strategies of SARS-CoV-2. Nat Rev Microbiol 2023;:1-17. [PMID: 36631691 DOI: 10.1038/s41579-022-00839-1] [Reference Citation Analysis]
3 Mpekoulis G, Kalliampakou KI, Milona RS, Lagou D, Ioannidis A, Jahaj E, Chasapis CT, Kefallinos D, Karakasiliotis I, Kotanidou A, Chatzipanagiotou S, Vassilacopoulou D, Vassiliou AG, Angelakis E, Vassilaki N. Significance of Catecholamine Biosynthetic/Metabolic Pathway in SARS-CoV-2 Infection and COVID-19 Severity. Cells 2022;12. [PMID: 36611805 DOI: 10.3390/cells12010012] [Reference Citation Analysis]
4 Saber MM, Nomair AM, Osman AM, Nomeir HM, Farag NM. Endothelial Monocyte-Activating Polypeptide-II Is an Indicator of Severity and Mortality in COVID-19 Patients. Vaccines (Basel) 2022;10. [PMID: 36560587 DOI: 10.3390/vaccines10122177] [Reference Citation Analysis]
5 Soni S, Mebratu YA. B-cell lymphoma-2 family proteins-activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus-2: Killing two birds with one stone? Rev Med Virol 2022;:e2411. [PMID: 36451345 DOI: 10.1002/rmv.2411] [Reference Citation Analysis]
6 Godoy-Tena G, Barmada A, Morante-Palacios O, de la Calle-Fabregat C, Martins-Ferreira R, Ferreté-Bonastre AG, Ciudad L, Ruiz-Sanmartín A, Martínez-Gallo M, Ferrer R, Ruiz-Rodriguez JC, Rodríguez-Ubreva J, Vento-Tormo R, Ballestar E. Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines. Genome Med 2022;14:134. [PMID: 36443794 DOI: 10.1186/s13073-022-01137-4] [Reference Citation Analysis]
7 Godoy-tena G, Barmada A, Morante-palacios O, de la Calle-fabregat C, Martins-ferreira R, Ferreté-bonastre AG, Ciudad L, Ruiz-sanmartín A, Martínez-gallo M, Ferrer R, Ruiz-rodriguez JC, Rodríguez-ubreva J, Vento-tormo R, Ballestar E. Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines.. [DOI: 10.1101/2022.10.24.22281485] [Reference Citation Analysis]
8 Gozzi-silva SC, Oliveira LDM, Alberca RW, Pereira NZ, Yoshikawa FS, Pietrobon AJ, Yendo TM, de Souza Andrade MM, Ramos YAL, Brito CA, Oliveira EA, Beserra DR, Orfali RL, Aoki V, Duarte AJDS, Sato MN. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients. Cells 2022;11:3359. [DOI: 10.3390/cells11213359] [Reference Citation Analysis]
9 Yang J, Yang M, Kim D, Kim B, Tark D, Kang S, Lee G. Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice.. [DOI: 10.21203/rs.3.rs-1988035/v1] [Reference Citation Analysis]
10 Rashid M, Glover KKM, Lao Y, Spicer V, Coombs KM. Temporal proteomic analyses of human lung cells distinguish high pathogenicity influenza viruses and coronaviruses from low pathogenicity viruses. Front Microbiol 2022;13:994512. [DOI: 10.3389/fmicb.2022.994512] [Reference Citation Analysis]
11 Nasir Arefinia, Amin Ramezani, Mehrdad Farokhnia, Ali Mohammad Arab Zadeh, Ramin Yaghobi, Jamal Sarvari. Association between expression of ZBP1, AIM2, and MDA5 genes and severity of COVID-19. EXCLI J 2022;21. [PMID: 36320810 DOI: 10.17179/excli2022-5141] [Reference Citation Analysis]
12 Menegazzi M, Gotte G. Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections. Int J Mol Sci 2022;23:6556. [PMID: 35742999 DOI: 10.3390/ijms23126556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zhu Z, Shi J, Li L, Wang J, Zhao Y, Ma H. Therapy Targets SARS-CoV-2 Infection-Induced Cell Death. Front Immunol 2022;13:870216. [PMID: 35655782 DOI: 10.3389/fimmu.2022.870216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Majchrzak M, Poręba M. The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic. Pharmacol Rep 2022;74:1149-65. [PMID: 35997950 DOI: 10.1007/s43440-022-00394-9] [Reference Citation Analysis]